AAAAAA
Results: 1-25/33
Authors:
Montes-Mico, R
Charman, WN
Citation: R. Montes-mico et Wn. Charman, Choice of spatial frequency for contrast sensitivity evaluation after corneal refractive surgery, J REFRACT S, 17(6), 2001, pp. 646-651
Authors:
Porter, CJH
Charman, WN
Citation: Cjh. Porter et Wn. Charman, Lipid-based formulations for oral administration: Opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs (Reprinted from Drug Targeting Technology: Physical - Chemical - Biological Methods - Drugs and the Pharmaceutical Sciences, vol 115, pg 85-130, 2001), J RECEPT SI, 21(2-3), 2001, pp. 215-257
Authors:
Heron, G
Charman, WN
Schor, CM
Citation: G. Heron et al., Age changes in the interactions between the accommodation and vergence systems, OPT VIS SCI, 78(10), 2001, pp. 754-762
Authors:
Hauge, E
Naroo, SA
Charman, WN
Citation: E. Hauge et al., Poly(methyl methacrylate) model study of optical surface quality after excimer laser photorefractive keratectomy, J CAT REF S, 27(12), 2001, pp. 2026-2035
Authors:
Sek, L
Porter, CJH
Charman, WN
Citation: L. Sek et al., Characterisation and quantification of medium chain and long chain triglycerides and their in vitro digestion products, by HPTLC coupled with in situdensitometric analysis, J PHARM B, 25(3-4), 2001, pp. 651-661
Authors:
Montes-Mico, R
Charman, WN
Citation: R. Montes-mico et Wn. Charman, Intraocular pressure after excimer laser myopic refractive surgery, OPHTHAL PHY, 21(3), 2001, pp. 228-235
Authors:
Kalsi, M
Heron, G
Charman, WN
Citation: M. Kalsi et al., Changes in the static accommodation response with age, OPHTHAL PHY, 21(1), 2001, pp. 77-84
Authors:
Porter, CJH
Charman, WN
Citation: Cjh. Porter et Wn. Charman, Preface - Transport and absorption of drugs via the lymphatic system, ADV DRUG DE, 50(1-2), 2001, pp. 1-2
Authors:
Edwards, GA
Porter, CJH
Caliph, SM
Khoo, SM
Charman, WN
Citation: Ga. Edwards et al., Animal models for the study of intestinal lymphatic drug transport, ADV DRUG DE, 50(1-2), 2001, pp. 45-60
Authors:
Porter, CJH
Charman, WN
Citation: Cjh. Porter et Wn. Charman, Intestinal lymphatic drug transport: an update, ADV DRUG DE, 50(1-2), 2001, pp. 61-80
Authors:
Porter, CJH
Charman, WN
Citation: Cjh. Porter et Wn. Charman, In vitro assessment of oral lipid based formulations, ADV DRUG DE, 50, 2001, pp. S127-S147
Authors:
Heron, G
Charman, WN
Schor, C
Citation: G. Heron et al., Dynamics of the accommodation response to abrupt changes in target vergence as a function of age, VISION RES, 41(4), 2001, pp. 507-519
Authors:
Pennie, FC
Wood, ICJ
Olsen, C
White, S
Charman, WN
Citation: Fc. Pennie et al., A longitudinal study of the biometric and refractive changes in full-term infants during the first year of life, VISION RES, 41(21), 2001, pp. 2799-2810
Authors:
Khoo, SM
Edwards, GA
Porter, CJH
Charman, WN
Citation: Sm. Khoo et al., A conscious dog model for assessing the absorption, enterocyte-based metabolism, and intestinal lymphatic transport of halofantrine, J PHARM SCI, 90(10), 2001, pp. 1599-1607
Authors:
Porter, CJH
Charman, WN
Citation: Cjh. Porter et Wn. Charman, Lipid-based formulations for oral administration - Opportunities for bioavailability enhancement and lipoprotein targeting of lipophilic drugs, DRUG PHARM, 115, 2001, pp. 85-130
Authors:
Naroo, SA
Charman, WN
Citation: Sa. Naroo et Wn. Charman, Changes in posterior corneal curvature after photorefractive keratectomy, J CAT REF S, 26(6), 2000, pp. 872-878
Authors:
Khoo, SM
Porter, CJH
Charman, WN
Citation: Sm. Khoo et al., The formulation of Halofantrine as either non-solubilising PEG 6000 or solubilising lipid based solid dispersions: Physical stability and absolute bioavailability assessment, INT J PHARM, 205(1-2), 2000, pp. 65-78
Authors:
Lyons, KC
Charman, WN
Miller, R
Porter, CJH
Citation: Kc. Lyons et al., Factors limiting the oral bioavailability of N-acetylglucosaminyl-N-acetylmuramyl dipeptide (GMDP) and enhancement of absorption in rats by delivery in a water-in-oil microemulsion, INT J PHARM, 199(1), 2000, pp. 17-28
Authors:
Charman, WN
Jennings, JAM
Citation: Wn. Charman et Jam. Jennings, Does ocular retraction change with ambient temperature?, OPHTHAL PHY, 20(5), 2000, pp. 408-410
Authors:
Charman, WN
Heron, G
Citation: Wn. Charman et G. Heron, On the linearity of accommodation dynamics, VISION RES, 40(15), 2000, pp. 2057-2066
Authors:
Charman, WN
Citation: Wn. Charman, Lipids, lipophilic drugs, and oral drug delivery - Some emerging concepts, J PHARM SCI, 89(8), 2000, pp. 967-978
Authors:
Caliph, SM
Charman, WN
Porter, CJH
Citation: Sm. Caliph et al., Effect of short-, medium-, and long-chain fatty acid-based vehicles on theabsolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats, J PHARM SCI, 89(8), 2000, pp. 1073-1084
Authors:
Koh, LH
Charman, WN
Citation: Lh. Koh et Wn. Charman, Size constancy and angular size matching in size perception of near objects, OPT VIS SCI, 76(4), 1999, pp. 241-246
Authors:
Charman, WN
Citation: Wn. Charman, Near vision, lags of accommodation and myopia, OPHTHAL PHY, 19(2), 1999, pp. 126-133
Authors:
Charman, WN
Chan, HK
Finnin, BC
Charman, SA
Citation: Wn. Charman et al., Drug delivery: A key factor in realising the full therapeutic potential ofdrugs, DRUG DEV R, 46(3-4), 1999, pp. 316-327